US Patent 10066201 Ex vivo proliferation of epithelial cells
Patent 10066201 was granted and assigned to Propagenix Inc. on September, 2018 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
September 7, 2016
Date of Patent
September 4, 2018
Patent Applicant
Patent Application Number
15258751
Patent Citations Received
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10066201 Ex vivo proliferation of epithelial cells
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.